期刊文献+

间充质干细胞诱导体外分化来的初始T细胞表型变化的实验研究 被引量:1

Induction of phenotype variance of naive T cell derived in vitro from mesenchymal stem cells
原文传递
导出
摘要 目的将体外由CD34^+细胞分化而来的初始T细胞与异基因骨髓间充质干细胞(MSC)共孵育,观察初始T细胞表型的变化。方法传3代以上的MSC与脐血CD34^+刍细胞分化的初始T细胞共孵育1周,用流式细胞仪检测其表型变化。结果与对照组相比,CD8^+细胞明显增加(共孵育组(35.9±6.3)%,单纯初始T细胞培养组(18.4±4.5)%],且CD8^+;CD3^+细胞明显增加[共孵育组(27.6±2.8)%,单纯初始T细胞培养组(15.2±3.1)%]。结论骨髓MSC在体外与异基因初始T淋巴细胞共孵育使CD8^+初始T细胞表达增加,这种变化可能与其诱导免疫耐受相关。 Objective Donor derived naive T cells initiated GVHD by contacting with, mesenchymal stem cells (MSC) have been used to prevent or treat graft-versus-host disease (GVHD). although we still puzzle about its mechanisms. Observe the effect of MSC on phenotypes of Naive T cell to study the mechanism of MSC immunomodulation. Methods After 3 passages, MSC was incubated with Naive T cell differentiated from cord blood CD^34+ cells in vitro. Then the variances of naive T cell phenotypes were analyzed by flow cytometric. Results CD8^+ T cells were relatively increased after 7 days co-culture with allogenie MSC when compared to control: (35.9±6.3)% vs (18.4±4.5)%. CD8^+ CD; cells also showed the same trend (27.6±2.8)% vs (15.2±3.1)%. Conclusion MSC may partly reduce the incidence of GVHD by increase of CD8^+ naive T cell. The result may provide new clue to explain immunoregulatory mechanism of MSC.
出处 《白血病.淋巴瘤》 CAS 2009年第1期1-4,共4页 Journal of Leukemia & Lymphoma
基金 国家高技术发展规划项目863项目(2001AA217131)
关键词 间质干细胞 初始T细胞 免疫调节 Mesenchymal stem cell Naive T cells Immunomodulatory
  • 相关文献

参考文献8

  • 1Lee ST, Jang JH, Cheong JW, et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002, 118:1128-113:1.
  • 2Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant,severe, acute graft-versus-host disease: a phase II study. Lancet, 2008, 371: 1579-1586.
  • 3Nauta A J, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood, 2007, 110: 3499-3506.
  • 4Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animal. Blood, 2003, 102: 3837-3844.
  • 5宁红梅,金建刚,扈江伟,冯凯,陈虎.人骨髓间充质干细胞体外对异基因T淋巴细胞表型的影响[J].中国实验血液学杂志,2005,13(1):43-49. 被引量:22
  • 6张伟,葛薇,李长虹,尤胜国,韩钦,邓为民,赵春华.骨髓间充质干细胞通过上调CD8^+CD28^-T细胞抑制T细胞的增殖[J].中国实验血液学杂志,2004,12(5):666-669. 被引量:17
  • 7Prevosto C, Zancolli M. Generation of CD4^+ or CD8^+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica, 2007, 92: 881-888.
  • 8Gardner JP, Rosenzweig M, Marks DF, et al. T-lymphopoietic capacity of cord blood-derived CD34^+ progenitor cells. Exp Hematol, 1998, 26: 991-999.

二级参考文献26

  • 1Le-Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibolity complex.Scand J Immunol 2003; 57:11 -20
  • 2Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mensenchymal progenitor cells. J cell physiol,1999; 181:67-73
  • 3Devine SM. Mesenchymal Stem Cells: will they have a role in the clinic? J Cell Biochem (Suppl), 2002; 38:73-79
  • 4Kircher B, Stevanovic S, Urbanek I, et al. Induction of HA-I-specific cytotoxic T-cell clones parallels the therapeutic effect of donor Iymphocyte infusion. Br. J Haematol, 2002; 117: 935 - 939
  • 5Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002;418: 41 - 49
  • 6Klyushnenkova E, Mosca J, Mclntosh K. Human mesenchymal stem cells suppress allergenic T cell responses in vitro: implications for allergenic transplantation. Blood, 1998; 92: 642a
  • 7McIntosh K, Klyushnenkova E, Shustova V, et al. Suppression of alloreactive T cell response by human mesenchymal stem cells involves CD8+ cells. Blood, 1999; 94: 123a
  • 8Lazarus H, Curtin P, Devine S, et al. Role of mesenchymal stem cells(MSC) in allogeneic transplantaion: early phase Ⅰ clinical results. Blood, 2000; 96: 392a
  • 9Cohen JL, Trenado A, Vasey D, et al. CD4+ CD25+ Immunoregulatory T cells: mew therapeutics for graft-versus-host disease. J Exp Med, 2002; 196:401-406
  • 10Nakamura K, Kitani A, Strober W. Cell contact-dependent im-munosuppression by CD4 + CD25 + regulatory T cells is mediated by cell surface bound transforming growth factor beta. J Exp Med, 2001;194:629 - 644

共引文献35

同被引文献8

  • 1Abdallah BM,Kassem M.Human mesenchymal stem cells.Basic Biol,2008,15:109-116.
  • 2Sioud M,Mobergslien A,Boudabous A,et al.Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation.Scand J Immunol,2010,71:267-274.
  • 3Di Nicola M,Carlo-Stella C,Magni M,et al.Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspeeific mitogenic stimuli.Blood,2002,99:3838-3843.
  • 4Archambault MP,McIntosh KR,Butterfield AM,et al.Allogeneic mesenchymal stem cells persist and function in an irnmunocompetent non-human primate model.Blood,2001,98:648a.
  • 5Zhang X,Jiao C,Zhao S. Role of mesenchymal stem cells in immunological rejection of organ transplantation.Stem Cell Rev,2009,5:402-409.
  • 6Bartholomew A,Sturgeon C,Siatskas M,et al.Mesenchymal stem cell suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.Experimental Hematology,2002,30:42-48.
  • 7Zappia E,Casazza S,Pedemonte E,et al.Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing Tcell anergy.Blood,2005,106:1755-1761.
  • 8张伟,杨默,陈志峰.骨髓间充质干细胞对T细胞亚群的影响[J].中国实验血液学杂志,2008,16(4):863-866. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部